OptMed, Inc. — Form D
OptMed, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2012-02-03. The offering totals $2.0M, of which $322K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2012-02-03
- Form: D
- Accession: 0001019056-12-000107
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $2.0M
- Amount sold: $322K
- Remaining: $1.7M
- Minimum investment: $10K
- Investors: 4
- Date of first sale: 2012-01-23
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-172866
Issuer
- Name: OptMed, Inc.
- CIK: 0001469988
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2007
- Address: 601 LEXINGTON AVENUE, SUITE 5100, NEW YORK, NY, 10022
- Phone: (212) 867-4141
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Howard Schrayer | Director | New York, NY |
| Alain Klapholz | Promoter | New York, NY |
| Martin Sands | Director | New York, NY |
| Steven Sands | Director | New York, NY |
| Sanket Parekh | Director | Plantation, FL |
| Ervin Braun | Director | New York, NY |
| Ervin Braun | Executive Officer | New York, NY |
| Kevin McKim | Director | New York, NY |
| Alain Klapholz | Director | New York, NY |
| Alain Klapholz | Executive Officer | New York, NY |
| Jeffrey Berg | Director | Woodmere, NY |
| Martin Knopf | Executive Officer | Woodmere, NY |
Other filings by this issuer (8)
More